المؤلفون: Ke J; Department of Thoracic Surgery, Gaozhou People's Hospital Affiliated to Guangdong Medical University, Maoming, China., Xie Y; Department of Thoracic Surgery, Gaozhou People's Hospital Affiliated to Guangdong Medical University, Maoming, China., Huang S; Department of Cardiothoracic Surgery, Guangdong Medical University, Zhanjiang, China., Wang W; Graduate School of Guangdong Medical University, Zhanjiang, China., Zhao Z; Department of Cardiothoracic Surgery, Guangdong Medical University, Zhanjiang, China., Lin W; Department of Thoracic Surgery, Gaozhou People's Hospital Affiliated to Guangdong Medical University, Maoming, China. Electronic address: wanliLin2020@163.com.

المصدر: Asian journal of surgery [Asian J Surg] 2024 Sep; Vol. 47 (9), pp. 3827-3840. Date of Electronic Publication: 2024 Mar 05.

نوع المنشور: Systematic Review; Journal Article; Meta-Analysis; Comparative Study; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8900600 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0219-3108 (Electronic) Linking ISSN: 10159584 NLM ISO Abbreviation: Asian J Surg Subsets: MEDLINE

مواضيع طبية MeSH: Esophageal Neoplasms*/therapy , Esophageal Neoplasms*/mortality , Esophageal Neoplasms*/pathology , Neoadjuvant Therapy* , Chemoradiotherapy* , Esophagectomy*, Humans ; Survival Rate ; Treatment Outcome ; Combined Modality Therapy ; Chemoradiotherapy, Adjuvant

عنوان ترانسليتريتد: 5-Jahres-Follow-up der RAPIDO-Studie: Zurück in die Zukunft der Langzeitradiochemotherapie bei totaler neoadjuvanter Therapie (TNT) des lokal fortgeschrittenen Rektumkarzinoms?

المؤلفون: Edelmann M; Department of Radiotherapy and Radiation Oncology, University Medical Center Göttingen, Robert-Koch-Straße 40, 37075, Göttingen, Deutschland.; Göttingen Comprehensive Cancer Center (G-CCC), University Medical Center Göttingen, Von-Bar-Str. 2/4, 37075, Göttingen, Deutschland., Rieken S; Department of Radiotherapy and Radiation Oncology, University Medical Center Göttingen, Robert-Koch-Straße 40, 37075, Göttingen, Deutschland.; Göttingen Comprehensive Cancer Center (G-CCC), University Medical Center Göttingen, Von-Bar-Str. 2/4, 37075, Göttingen, Deutschland., Dröge LH; Department of Radiotherapy and Radiation Oncology, University Medical Center Göttingen, Robert-Koch-Straße 40, 37075, Göttingen, Deutschland. Hendrik.droege@med.uni-goettingen.de.; Göttingen Comprehensive Cancer Center (G-CCC), University Medical Center Göttingen, Von-Bar-Str. 2/4, 37075, Göttingen, Deutschland. Hendrik.droege@med.uni-goettingen.de.

المصدر: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] [Strahlenther Onkol] 2024 Jul; Vol. 200 (7), pp. 649-651. Date of Electronic Publication: 2024 Apr 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Urban & Vogel Country of Publication: Germany NLM ID: 8603469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-099X (Electronic) Linking ISSN: 01797158 NLM ISO Abbreviation: Strahlenther Onkol Subsets: MEDLINE

مواضيع طبية MeSH: Rectal Neoplasms*/therapy , Rectal Neoplasms*/radiotherapy , Rectal Neoplasms*/pathology , Neoadjuvant Therapy* , Chemoradiotherapy*/methods, Humans ; Follow-Up Studies ; Neoplasm Staging ; Chemoradiotherapy, Adjuvant ; Survival Rate ; Treatment Outcome ; Male ; Female

المؤلفون: Lee YD; Department of Radiology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, #23 Kyungheedae-ro, Dongdaemun-gu, 02447, Seoul, Republic of Korea.; Department of Medicine, Kyung Hee University College of Medicine, 23 Kyungheedae-ro, Dongdaemun-gu, 02447, Seoul, Republic of Korea., Kim HG; Department of Radiology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, #23 Kyungheedae-ro, Dongdaemun-gu, 02447, Seoul, Republic of Korea., Seo M; Department of Medicine, Kyung Hee University College of Medicine, 23 Kyungheedae-ro, Dongdaemun-gu, 02447, Seoul, Republic of Korea., Moon SK; Department of Radiology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, #23 Kyungheedae-ro, Dongdaemun-gu, 02447, Seoul, Republic of Korea., Park SJ; Department of Radiology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, #23 Kyungheedae-ro, Dongdaemun-gu, 02447, Seoul, Republic of Korea., You MW; Department of Radiology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, #23 Kyungheedae-ro, Dongdaemun-gu, 02447, Seoul, Republic of Korea. funfun2020@khu.ac.kr.

المصدر: International journal of colorectal disease [Int J Colorectal Dis] 2024 May 24; Vol. 39 (1), pp. 78. Date of Electronic Publication: 2024 May 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 8607899 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1262 (Electronic) Linking ISSN: 01791958 NLM ISO Abbreviation: Int J Colorectal Dis Subsets: MEDLINE

مواضيع طبية MeSH: Rectal Neoplasms*/therapy , Rectal Neoplasms*/diagnostic imaging , Rectal Neoplasms*/pathology , Machine Learning* , Neoadjuvant Therapy* , Magnetic Resonance Imaging* , Chemoradiotherapy*, Humans ; Male ; Female ; Middle Aged ; Aged ; Treatment Outcome ; ROC Curve ; Adult ; Neoplasm Grading ; Chemoradiotherapy, Adjuvant ; Radiomics

المؤلفون: Kim HJ; Department of Radiation Oncology, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea., Lee J; Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Lee KB; Department of Obstetrics and Gynecology, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea., Sung K; Department of Radiation Oncology, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea., Kim YB; Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: ybkim3@yuhs.ac., Kim YS; Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea. Electronic address: zoomboom@hanmail.net.

المصدر: Gynecologic oncology [Gynecol Oncol] 2024 Mar; Vol. 182, pp. 39-44. Date of Electronic Publication: 2024 Jan 20.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Chemoradiotherapy, Adjuvant*/adverse effects , Endometrial Neoplasms*/drug therapy , Endometrial Neoplasms*/surgery, Female ; Humans ; Retrospective Studies ; Chemoradiotherapy ; Combined Modality Therapy ; Chemotherapy, Adjuvant ; Neoplasm Staging ; Radiotherapy, Adjuvant

المؤلفون: Yang J; Department of General Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China., Deng Q; Department of General Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China., Cheng Y; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China., Fu Z; Department of General Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China., Wu X; Department of General Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China. 15123329631@163.com.

المصدر: World journal of surgical oncology [World J Surg Oncol] 2024 Jan 25; Vol. 22 (1), pp. 31. Date of Electronic Publication: 2024 Jan 25.

نوع المنشور: Journal Article; Meta-Analysis

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819 (Electronic) Linking ISSN: 14777819 NLM ISO Abbreviation: World J Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Chemoradiotherapy* , Rectal Neoplasms*/pathology, Humans ; Chemoradiotherapy, Adjuvant ; Chemotherapy, Adjuvant ; Disease-Free Survival ; Neoadjuvant Therapy ; Neoplasm Staging ; Pathologic Complete Response ; Retrospective Studies ; Treatment Outcome

المؤلفون: Bao H; Department of Oncology, The Affiliated Panyu Center Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.; Cancer Institute of Panyu, Guangzhou, China., Bao H; Department of Psychosomatic Medicine, Chongqing University Three Gorges Hospital, Wanzhou, Chongqing, China., Lin L; Department of Oncology, The Affiliated Panyu Center Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.; Cancer Institute of Panyu, Guangzhou, China., Wang Y; Department of Oncology, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China., Zhang L; Department of Oncology, Chongqing University Three Gorges Hospital, Wanzhou, Chongqing, China., Zhang L; Department of Oncology, Chongqing University Three Gorges Hospital, Wanzhou, Chongqing, China., Zhang H; Department of Oncology, Chongqing University Three Gorges Hospital, Wanzhou, Chongqing, China., Liu L; Department of Oncology, The Affiliated Panyu Center Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.; Cancer Institute of Panyu, Guangzhou, China., Cao X; Department of Oncology, The Affiliated Panyu Center Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.; Cancer Institute of Panyu, Guangzhou, China.

المصدر: PeerJ [PeerJ] 2024 Sep 11; Vol. 12, pp. e18065. Date of Electronic Publication: 2024 Sep 11 (Print Publication: 2024).

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: PeerJ Inc Country of Publication: United States NLM ID: 101603425 Publication Model: eCollection Cited Medium: Internet ISSN: 2167-8359 (Electronic) Linking ISSN: 21678359 NLM ISO Abbreviation: PeerJ Subsets: MEDLINE

مواضيع طبية MeSH: Esophageal Neoplasms*/therapy , Esophageal Neoplasms*/mortality , Esophageal Neoplasms*/complications , Liver Cirrhosis*/complications , Liver Cirrhosis*/mortality , Chemoradiotherapy*/adverse effects , Chemoradiotherapy*/methods, Humans ; Middle Aged ; Male ; Aged ; Female ; Retrospective Studies ; Treatment Outcome

المؤلفون: Mukherjee S; Oxford Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: somnath.mukherjee@ouh.nhs.uk., Qi C; Centre for Statistics in Medicine, University of Oxford, Oxford, UK., Shaw R; Oncology Clinical Trials Office (OCTO), Department of Oncology, University of Oxford, Oxford, UK., Jones CM; Department of Oncology, University of Cambridge, Cambridge, UK; Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Bridgewater JA; UCL Cancer Institute, University College London Hospitals NHS Foundation Trust, London, UK., Radhakrishna G; The Christie Hospital, The Christie Hospitals NHS Foundation Trust, Manchester, UK., Patel N; Department of Radiology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Holmes J; Centre for Statistics in Medicine, University of Oxford, Oxford, UK., Virdee PS; Centre for Statistics in Medicine, University of Oxford, Oxford, UK., Tranter B; Velindre Cancer Centre, Velindre University NHS Trust, Cardiff, UK., Parsons P; Velindre Cancer Centre, Velindre University NHS Trust, Cardiff, UK., Falk S; Bristol Cancer Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, UK., Wasan HS; Department of Surgery & Cancer, Imperial College London, London, UK., Ajithkumar TV; Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Holyoake D; Norfolk & Norwich University Hospital, Norfolk & Norwich University Hospitals NHS Foundation Trust, Norwich, UK., Roy R; Queen's Centre for Oncology, Hull University Teaching Hospitals NHS Trust, Hull, UK., Scott-Brown M; Coventry Cancer Centre, University Hospital Coventry & Warwickshire, Coventry, UK., Hurt CN; Centre for Trials Research, Cardiff University, Cardiff, UK., O'Neill E; Department of Oncology, University of Oxford, Oxford, UK., Sebag-Montefiore D; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Maughan TS; Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK., Hawkins MA; Department of Medical Physics & Biomedical Engineering, University College London, London, UK., Corrie P; Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Sep; Vol. 209, pp. 114236. Date of Electronic Publication: 2024 Jul 23.

نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Clinical Trial, Phase I

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Nelfinavir*/therapeutic use , Nelfinavir*/administration & dosage , Nelfinavir*/adverse effects , Pancreatic Neoplasms*/therapy , Pancreatic Neoplasms*/pathology , Pancreatic Neoplasms*/drug therapy , Pancreatic Neoplasms*/mortality , Chemoradiotherapy*/adverse effects , Chemoradiotherapy*/methods , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Paclitaxel/administration & dosage ; Paclitaxel/adverse effects ; Maximum Tolerated Dose ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/administration & dosage ; Deoxycytidine/adverse effects ; Deoxycytidine/therapeutic use ; Gemcitabine ; Aged, 80 and over ; Quality of Life ; Albumins/administration & dosage ; Albumins/therapeutic use ; Albumins/adverse effects ; Progression-Free Survival ; Protease Inhibitors/adverse effects ; Protease Inhibitors/therapeutic use ; Protease Inhibitors/administration & dosage

المؤلفون: Li C; Department of Critical Care, West China Hospital, Sichuan University, No. 363, Section 3, Furong Avenue, Wenjiang District, Chengdu, 611100, China., Zhang S; Department of Critical Care, West China Hospital, Sichuan University, No. 363, Section 3, Furong Avenue, Wenjiang District, Chengdu, 611100, China., Liu Y; Department of Critical Care, West China Hospital, Sichuan University, No. 363, Section 3, Furong Avenue, Wenjiang District, Chengdu, 611100, China., Hu T; Department of Critical Care, West China Hospital, Sichuan University, No. 363, Section 3, Furong Avenue, Wenjiang District, Chengdu, 611100, China., Wang C; Department of Critical Care, West China Hospital, Sichuan University, No. 363, Section 3, Furong Avenue, Wenjiang District, Chengdu, 611100, China. lichunrong8182@163.com.

المصدر: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Aug 10; Vol. 32 (9), pp. 583. Date of Electronic Publication: 2024 Aug 10.

نوع المنشور: Journal Article; Meta-Analysis; Systematic Review; Review

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Randomized Controlled Trials as Topic* , Neoadjuvant Therapy*/methods , Neoplasms*/therapy , Neoplasms*/complications , Nutritional Status* , Chemoradiotherapy*/methods , Chemoradiotherapy*/adverse effects , Malnutrition*/etiology , Malnutrition*/prevention & control, Humans ; Quality of Life

المؤلفون: You J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Haidian District, Beijing, China., Yuan Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Haidian District, Beijing, China., Gu X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Haidian District, Beijing, China., Wang W; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Haidian District, Beijing, China. wangweihu88@163.com., Li X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Haidian District, Beijing, China. lxflp@163.com.

المصدر: BMC cancer [BMC Cancer] 2024 Jul 12; Vol. 24 (1), pp. 833. Date of Electronic Publication: 2024 Jul 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Uterine Cervical Neoplasms*/therapy , Chemoradiotherapy*/adverse effects , Chemoradiotherapy*/methods , Granulocyte Colony-Stimulating Factor*/therapeutic use , Granulocyte Colony-Stimulating Factor*/administration & dosage , Polyethylene Glycols*/administration & dosage , Polyethylene Glycols*/therapeutic use , Polyethylene Glycols*/adverse effects , Recombinant Proteins*/administration & dosage , Recombinant Proteins*/therapeutic use , Neutropenia*/prevention & control , Neutropenia*/etiology, Humans ; Female ; Middle Aged ; Adult ; Prospective Studies ; Aged ; Cisplatin/adverse effects ; Cisplatin/therapeutic use ; Cisplatin/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Young Adult ; Adolescent ; Paclitaxel/adverse effects ; Paclitaxel/administration & dosage ; Paclitaxel/therapeutic use

المؤلفون: Shen Y; Department of Stomatology, Affiliated Hospital of Shaoxing University, Shaoxing, 312000, China., Shan J; Department of Stomatology, Affiliated Hospital of Shaoxing University, Shaoxing, 312000, China. shanjiebo21@163.com.

المصدر: World journal of surgical oncology [World J Surg Oncol] 2024 Jul 11; Vol. 22 (1), pp. 181. Date of Electronic Publication: 2024 Jul 11.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819 (Electronic) Linking ISSN: 14777819 NLM ISO Abbreviation: World J Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Salivary Gland Neoplasms*/therapy , Salivary Gland Neoplasms*/pathology , Salivary Gland Neoplasms*/mortality , Chemoradiotherapy*/methods , Chemoradiotherapy*/mortality , Neoplasm Recurrence, Local*/pathology , Neoplasm Recurrence, Local*/prevention & control , Neoplasm Recurrence, Local*/therapy , Neoplasm Recurrence, Local*/epidemiology, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Survival Rate ; Follow-Up Studies ; Aged ; Prognosis ; Adult ; Neoplasm Staging ; Propensity Score ; Radiotherapy, Adjuvant/methods